Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives.

International journal of hematology·2026

Same author

Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia.

Blood·2026

Same author

The Natural Quassinoid Brusatol Enhances Venetoclax Efficacy and Overcomes Resistance in Myeloid Leukemias.

Cancer science·2026

Same author

Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

Blood advances·2026

Same author

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2.

Leukemia·2026

Same author

PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.

Blood advances·2026

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Xenograft models for normal and malignant stem cells.

Susumu Goyama¹, Mark Wunderlich¹, James C Mulloy¹

¹Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH.

|March 13, 2015

Summary

This summary is machine-generated.

Recent advances in immunodeficient mouse models and xenograft techniques significantly enhance the study of human hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs) in vivo.

More Related Videos

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Published on: July 29, 2016

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Related Experiment Videos

Last Updated: Apr 16, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Published on: July 29, 2016

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Area of Science:

Hematology
Immunology
Cancer Biology

Background:

Humanized mouse models have revolutionized the study of hematopoiesis and leukemia.
Previous reviews have detailed the historical development and application of immunodeficient mice for HSC and LSC research.

Purpose of the Study:

To provide an updated review of the latest mouse models and technical approaches for studying human normal and malignant hematopoiesis in vivo.
To highlight recent scientific findings from xenograft studies and discuss ongoing limitations.

Main Methods:

Review of recent literature on immunodeficient mouse models and xenograft techniques.
Focus on advancements in humanizing mice and chemotherapy testing models.

Main Results:

Newer mouse models and improved techniques offer enhanced capabilities for studying human HSC and LSC biology.
Advancements include methods for humanizing mice without extensive HSC purification and models for chemotherapy efficacy testing.

Conclusions:

The latest generation of immunodeficient mouse models and xenograft approaches represent significant progress in in vivo hematopoiesis research.
Despite advancements, challenges remain in fully recapitulating human HSC and LSC behavior in mouse models.